R&D and Product Overview

We specialize in the development of high-potential innovative biopharmaceutical solutions of non-monoclonal antibodies and specific dosage forms that require an advanced level of technological capabilities.

Long-Acting Protein Drug Development Technology and Protein Drug Development Technology Platform

At UBI Pharma, from the initial product development stage of selecting high-yielding cell lines, developing custom assays, performing validation and functional testing to the final phase of design and execution of clinical trials, our professional research teams turn ideas into products.


Using this technology platform in combination with our unique long-acting technology, our protein drugs are designed to have a high level of quality with the benefits of high yielding rates and long-lasting effects, creating extra value for our products.